Endofotonics
Identifying Early-stage Cancers Through In vivo Molecular Diagnosis
Founded 2013
Singapore
4 employees
Series B
Total: $9.06M
Biotechnology, Health Care +1
Singapore
4 employees
Series B
Total: $9.06M
Biotechnology, Health Care +1
General Information
Company Name
Endofotonics
Founded Year
2013
Location
Singapore
Singapore
Employees
4
Industries
Biotechnology, Health Care, Information Technology
Funding Stage
Series B
BounceWatch is an independent company data service, not affiliated with Endofotonics. To contact Endofotonics, visit endofotonics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Endofotonics compare?
A PDF of Endofotonics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Endofotonics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Singapore Market
Biotechnology
About Endofotonics
Business keywords: Medtech, Raman spectroscopy, Cancer detection, In-vivo diagnosis, Gastric cancer, Early-stage detection, Biomedical technology, Optics, Medical devices, Advanced manufacturing, Endoscopy, Spectroscopy platform, Series B funding, Asia Pacific commercialization, Lean team
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | $8.50M | 2 |
Beng Teck Liang, Tony Tan Choon Keat
|
29 May 2020 |
| Series A | Undisclosed | 2 |
|
01 Jan 2016 |
| Angel Round | $560.00K | - |
|
01 Apr 2014 |
Endofotonics Alternatives & Competitors
View All Alternatives
Endofotonics vs
Endofotonics vs
Endofotonics vs
Biomark Diagnostics Inc
Canada
Leading the world in early cancer detection research.
9 employees
Biotechnology, Health Care
FAQ About Endofotonics
Identifying Early-stage Cancers Through In vivo Molecular Diagnosis
Endofotonics was founded in 2013.
Endofotonics is headquartered in Singapore.
Endofotonics operates in Biotechnology, Health Care and Information Technology. Its work centres on Medtech, Raman spectroscopy, Cancer detection and In-vivo diagnosis.
Endofotonics has approximately 4 employees.
Endofotonics has completed 3 funding rounds, raising a total of $9.06M. The latest funding stage is Series B.
Top alternatives and competitors to Endofotonics include Dxcover, Reveal Surgical , Biomark Diagnostics Inc, Karkinos Healthcare. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Endofotonics and Dxcover are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Endofotonics, https://bouncewatch.com/company/endofotonics, updated 30 December 2024. When citing, please name BounceWatch and link this page.
